Bengt Glimelius
Researcher Next ID · RN-021226
Researcher · Medicine
Uppsala, Sweden
- Works count
- 996
- Citation count
- 75,947
- H-index
- 116
- i10-index
- 605
Research interests
Publications
Transformer-based biomarker prediction from colorectal cancer histology: A large-scale multicentric study
Cancer Cell · 2023 · https://doi.org/10.1016/j.ccell.2023.08.002
Compliance and tolerability of short-course radiotherapy followed by preoperative chemotherapy and surgery for high-risk rectal cancer – Results of the international randomized RAPIDO-trial
Radiotherapy and Oncology · 2020 · https://doi.org/10.1016/j.radonc.2020.03.011
Short-course radiotherapy followed by chemotherapy before total mesorectal excision (TME) versus preoperative chemoradiotherapy, TME, and optional adjuvant chemotherapy in locally advanced rectal cancer (RAPIDO): a randomised, open-label, phase 3 trial
The Lancet Oncology · 2020 · https://doi.org/10.1016/s1470-2045(20)30555-6
Patterns of Recurrence After Resection of Pancreatic Ductal Adenocarcinoma
JAMA Surgery · 2019 · https://doi.org/10.1001/jamasurg.2019.3337
Chemotherapy versus chemoradiotherapy after surgery and preoperative chemotherapy for resectable gastric cancer (CRITICS): an international, open-label, randomised phase 3 trial
The Lancet Oncology · 2018 · https://doi.org/10.1016/s1470-2045(18)30132-3
Comparison of adjuvant gemcitabine and capecitabine with gemcitabine monotherapy in patients with resected pancreatic cancer (ESPAC-4): a multicentre, open-label, randomised, phase 3 trial
The Lancet · 2017 · https://doi.org/10.1016/s0140-6736(16)32409-6
A pathology atlas of the human cancer transcriptome
Science · 2017 · https://doi.org/10.1126/science.aan2507
Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis
Journal of Clinical Oncology · 2014 · https://doi.org/10.1200/jco.2013.51.1857
Rectal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
Annals of Oncology · 2013 · https://doi.org/10.1093/annonc/mdt240
EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum
European Journal of Cancer · 2013 · https://doi.org/10.1016/j.ejca.2013.06.048
EURECCA colorectal: Multidisciplinary management: European consensus conference colon & rectum
European Journal of Cancer · 2013 · https://doi.org/10.1016/j.ejca.2013.06.048
Perioperative FOLFOX4 chemotherapy and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC 40983): long-term results of a randomised, controlled, phase 3 trial
The Lancet Oncology · 2013 · https://doi.org/10.1016/s1470-2045(13)70447-9
ESMO Consensus Guidelines for management of patients with colon and rectal cancer. A personalized approach to clinical decision making
Annals of Oncology · 2012 · 10.1093/annonc/mds236
Multicenter Randomized Phase II Clinical Trial Comparing Neoadjuvant Oxaliplatin, Capecitabine, and Preoperative Radiotherapy With or Without Cetuximab Followed by Total Mesorectal Excision in Patients With High-Risk Rectal Cancer (EXPERT-C)
Journal of Clinical Oncology · 2012 · https://doi.org/10.1200/jco.2011.39.6036
Effect of Adjuvant Chemotherapy With Fluorouracil Plus Folinic Acid or Gemcitabine vs Observation on Survival in Patients With Resected Periampullary Adenocarcinoma
JAMA · 2012 · 10.1001/jama.2012.7352
Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial
The Lancet Oncology · 2011 · https://doi.org/10.1016/s1470-2045(11)70097-3
Multidisciplinary Rectal Cancer Management: 2nd European Rectal Cancer Consensus Conference (EURECA-CC2)
Radiotherapy and Oncology · 2009 · https://doi.org/10.1016/j.radonc.2009.06.027
Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial
The Lancet · 2008 · https://doi.org/10.1016/s0140-6736(08)60455-9
Does chemotherapy prior to liver resection increase the potential for cure in patients with metastatic colorectal cancer? A report from the European Colorectal Metastases Treatment Group
European Journal of Cancer · 2007 · https://doi.org/10.1016/j.ejca.2007.07.017
Gemcitabine Plus Capecitabine Compared With Gemcitabine Alone in Advanced Pancreatic Cancer: A Randomized, Multicenter, Phase III Trial of the Swiss Group for Clinical Cancer Research and the Central European Cooperative Oncology Group
Journal of Clinical Oncology · 2007 · https://doi.org/10.1200/jco.2006.09.0886
Cumulative Absolute Breast Cancer Risk for Young Women Treated for Hodgkin Lymphoma
JNCI Journal of the National Cancer Institute · 2005 · https://doi.org/10.1093/jnci/dji290
Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease
JAMA · 2003 · https://doi.org/10.1001/jama.290.4.465
Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years
Journal of Clinical Oncology · 2002 · https://doi.org/10.1200/jco.2002.09.038
Mast cell infiltration correlates with poor prognosis in Hodgkin's lymphoma
British Journal of Haematology · 2002 · https://doi.org/10.1046/j.1365-2141.2002.03768.x
Preoperative Radiotherapy Combined with Total Mesorectal Excision for Resectable Rectal Cancer
New England Journal of Medicine · 2001 · https://doi.org/10.1056/nejmoa010580
A Prognostic Score for Advanced Hodgkin's Disease
New England Journal of Medicine · 1998 · 10.1056/nejm199811193392104
Current projects
No projects listed.